A clinical study to find the before and after changes of Vibheetakyadi Mashi Anjana(a type of Collyrium made from Belleric myrobalan etc drugs) in treating Suklarma(a fleshy outgrowth in white portion of eye)

A pre and Post Test study to evaluate the efficacy of Vibheetakyadi Mashi Anjana in the management of Suklarma

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014437

Enrollment

Registered

2018-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Suklarma(Pterygium)

Interventions

Intervention1: Vibheetakyadi Mashi Anjana in Suklarma(Pterygium): 30 Patients of Pterygium was selected Anjana applied in both eyes in morning for 14 days Intervention2: Vibheetakyadi mashi anjana (c

Eligibility

Inclusion criteria

Inclusion criteria: satisfying the diagnostic criteria either sex patients fit for Anjana karma

Exclusion criteria

Exclusion criteria: Suklarma(Pterygium) encroched in Krishna mandala(Cornea) Arma(Pterygium) indicated for Chedana(Excision) Arma(Pterygium) with any other ocular pathologies Like Abhisyanta(Conjunctivitis) Those Contraindicated for Anjana therapy(CCollyrium).

Design outcomes

Primary

Measure	Time frame
reduction in watering of eye reduction in foreign body sensation of eye reduction in pterygium massTimepoint: 2 month	—

Secondary

Measure	Time frame
reduction in watering of eyes reduction in foreign body sensation of eye reduction in Pterygium massTimepoint: 2 month	—

Countries

India

Contacts

Public ContactDr K Sivabalaji

Amrita School Of Ayurveda

drsubhadrapotty@yahoo.com9446479059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026